Committee for Orphan Medicinal Products (COMP): 10-11 December 2013

Date

Tuesday, 10 December 2013, All day

Location

European Medicines Agency, Amsterdam, the Netherlands

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

Documents

Share this page